SE0202719D0 - Process for mfg crystals of growth hormone - Google Patents

Process for mfg crystals of growth hormone

Info

Publication number
SE0202719D0
SE0202719D0 SE0202719A SE0202719A SE0202719D0 SE 0202719 D0 SE0202719 D0 SE 0202719D0 SE 0202719 A SE0202719 A SE 0202719A SE 0202719 A SE0202719 A SE 0202719A SE 0202719 D0 SE0202719 D0 SE 0202719D0
Authority
SE
Sweden
Prior art keywords
crystals
functional derivatives
growth hormone
mfg
propanol
Prior art date
Application number
SE0202719A
Other languages
Swedish (sv)
Inventor
Jonas Fransson
Mitra Mosharraf
Leena Lehtikari
Sinikka Uotila
Kalevi Visuri
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0202719A priority Critical patent/SE0202719D0/en
Publication of SE0202719D0 publication Critical patent/SE0202719D0/en
Priority to EP03795535A priority patent/EP1539797A1/en
Priority to PCT/SE2003/001422 priority patent/WO2004024753A1/en
Priority to BR0314187-0A priority patent/BR0314187A/en
Priority to AU2003259002A priority patent/AU2003259002A1/en
Priority to CA002498525A priority patent/CA2498525A1/en
Priority to JP2004535333A priority patent/JP2006513986A/en
Priority to MXPA05002826A priority patent/MXPA05002826A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A process is provided for manufacturing crystals of growth hormone (GH), or functional derivatives thereof, comprising the following steps : (a) preparing an aqueous solution of GH, or functional derivatives thereof, comprising 2-propanol, (b) incubating the solution prepared in step (a) to crystallize said GH, or functional derivatives thereof, and (c) isolating the crystals formed in step (b). A novel use of 2-propanol as a crystallizing agent for manufacturing crystals of GH, or functional derivatives thereof is also provided. In addition, crystals obtainable by the process and pharmaceutical compositions comprising the crystals are provided. The crystals are useful as a medicament, for the manufacture of such a medicament, and in a method of treating a mammal, including man.
SE0202719A 2002-09-13 2002-09-13 Process for mfg crystals of growth hormone SE0202719D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0202719A SE0202719D0 (en) 2002-09-13 2002-09-13 Process for mfg crystals of growth hormone
EP03795535A EP1539797A1 (en) 2002-09-13 2003-09-12 Process for manufacturing crystals of growth hormone
PCT/SE2003/001422 WO2004024753A1 (en) 2002-09-13 2003-09-12 Process for manufacturing crystals of growth hormone
BR0314187-0A BR0314187A (en) 2002-09-13 2003-09-12 Process for Producing Growth Hormone Crystals
AU2003259002A AU2003259002A1 (en) 2002-09-13 2003-09-12 Process for manufacturing crystals of growth hormone
CA002498525A CA2498525A1 (en) 2002-09-13 2003-09-12 Process for manufacturing crystals of growth hormone
JP2004535333A JP2006513986A (en) 2002-09-13 2003-09-12 Method for producing growth hormone crystals
MXPA05002826A MXPA05002826A (en) 2002-09-13 2003-09-12 Process for manufacturing crystals of growth hormone.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202719A SE0202719D0 (en) 2002-09-13 2002-09-13 Process for mfg crystals of growth hormone

Publications (1)

Publication Number Publication Date
SE0202719D0 true SE0202719D0 (en) 2002-09-13

Family

ID=20288983

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202719A SE0202719D0 (en) 2002-09-13 2002-09-13 Process for mfg crystals of growth hormone

Country Status (8)

Country Link
EP (1) EP1539797A1 (en)
JP (1) JP2006513986A (en)
AU (1) AU2003259002A1 (en)
BR (1) BR0314187A (en)
CA (1) CA2498525A1 (en)
MX (1) MXPA05002826A (en)
SE (1) SE0202719D0 (en)
WO (1) WO2004024753A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008132309A2 (en) * 2007-03-05 2008-11-06 Rhodia Operations Method for following up the crystallisation of a substance, and corresponding microfluidic device and screening method
GB201409451D0 (en) 2014-05-28 2014-07-09 Ipabc Ltd Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5109117A (en) * 1990-06-26 1992-04-28 Monsanto Company Method of somatotropin naturation using urea and a soluble organic alcohol
DK168790D0 (en) * 1990-07-13 1990-07-13 Novo Nordisk As
US5849704A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
SE9302278D0 (en) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab GROWTH HORMONE
JP3723857B2 (en) * 1998-02-04 2005-12-07 日本ケミカルリサーチ株式会社 Aqueous pharmaceutical composition containing human growth hormone

Also Published As

Publication number Publication date
CA2498525A1 (en) 2004-03-25
MXPA05002826A (en) 2005-09-30
WO2004024753A1 (en) 2004-03-25
EP1539797A1 (en) 2005-06-15
BR0314187A (en) 2005-08-09
AU2003259002A1 (en) 2004-04-30
JP2006513986A (en) 2006-04-27

Similar Documents

Publication Publication Date Title
AU2003216879A1 (en) Method for producing c13-alcohol mixtures
SE0100567D0 (en) Compounds
WO2005106090A3 (en) Preform produced by electrospinning, method for producting the same and use of such a preform
WO2005065185A3 (en) Temperature-stable formulations, and methods of development thereof
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
WO2004037789A8 (en) Methylene urea derivatives as raf-kinase inhibitors
TW200505505A (en) Process for modifying drug crystal formation
ATE319702T1 (en) METHOD FOR PRODUCING BENZOTHIOPHENE DERIVATIVES
ATE544445T1 (en) PRODUCTION OF STERILE AQUEOUS SUSPENSIONS WITH MICRONIZED CRYSTALLINE ACTIVE INGREDIENTS FOR INHALATION
PL362667A1 (en) Novel amlodipine camsylate and method for preparing thereof
EP1594885B8 (en) Medicament for inhibiting tumour growth
DK1383540T3 (en) Methods and pharmaceutical compositions for wound healing
WO2002102978A3 (en) Human growth hormone antagonists
ATE366107T1 (en) USE OF SULFODEHYDROABIETIC ACID TO TREAT INFLAMMATORY BOWEL DISEASE
WO2004087700A8 (en) Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
WO2003053337A3 (en) Therapeutic compositions
DE50301559D1 (en) PROCESS FOR THE PREPARATION OF TOCOTRIENOL-ENRICHED PREPARATIONS
SE0202719D0 (en) Process for mfg crystals of growth hormone
ATE428730T1 (en) METHOD FOR PRODUCING AN ALPHA-1 ANTITRYPSINE SOLUTION
PT1218401E (en) 4-BENZYLAMINOQUINOLINS CONTAINED WITH BILIARY ACID AND ITS HETEROCYCLICS METHODS OF THEIR PRODUCTION MEDICINES CONTAINING THESE COMPOUNDS AND ITS APPLICATION
WO2004009608A3 (en) Novel amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a, process for preparing the same, and use thereof
BRPI0306851A2 (en) application of polysaccharide derivatives as anti-infecting substances
SE9903611D0 (en) Novel compounds III
MXPA05013901A (en) Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition.
JP2004536810A5 (en)